[Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
D002191:Canrenoic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D011245:Pregnadienes / Q000627:therapeutic use*
D011245:Pregnadienes; D002191:Canrenoic Acid
Efficacia del canrenoato di K nel trattamento degli iperaldosteronismi secondari.